CIBC Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,908
| Closed | -$211K | – | 1434 |
|
|
2022
Q1 | $211K | Hold |
2,908
| – | – | ﹤0.01% | 1344 |
|
|
2021
Q4 | $245K | Buy |
2,908
+164
| +6% | +$13.8K | ﹤0.01% | 1221 |
|
|
2021
Q3 | $247K | Buy |
2,744
+295
| +12% | +$26.6K | ﹤0.01% | 1165 |
|
|
2021
Q2 | $234K | Hold |
2,449
| – | – | ﹤0.01% | 1172 |
|
|
2021
Q1 | $279K | Buy |
2,449
+195
| +9% | +$22.2K | ﹤0.01% | 1000 |
|
|
2020
Q4 | $312K | Buy |
+2,254
| New | +$312K | ﹤0.01% | 886 |
|